|
Surveillance
The
Florida Department of Health has several surveillance systems in place for
monitoring antimicrobial resistance in Florida.
·
S. aureus
o
In 2005, FDOH
began a partnership with Quest Diagnostics, a commercial laboratory that
primarily serves outpatient providers operating throughout Florida. Data
for all S. aureus isolates are shared with FDOH and their
susceptibility patterns are analyzed and reported here: MRSA
reports (coming soon)
o
In the
November 2008 revision to the FAC Rule 64D-3, Florida made
community-associated S. aureus mortality a reportable condition.
o
Additionally,
in November 2008, antibiotic susceptibilities for all S. aureus
isolates from sterile sites became reportable via electronic laboratory
reporting. That data has been coming in gradually and will be shared on
this page once it has been validated an analyzed.
·
S.
pneumoniae
o
S.
pneumoniae data for Florida
(2008)
o
Surveillance for Invasive Streptococcus pneumoniae
(2000)
·
Neisseria
meningitides
o
The emergence
of quinolone-resistant N. meningitidis in the U.S. has raised
important questions regarding current chemoprophylaxis guidelines and
highlights the expanding threat of antimicrobial resistance in bacterial
pathogens. The CDC responded to this threat by forming MeningNet, an
enhanced meningococcal surveillance system that will be used to monitor
antimicrobial susceptibility. As part of MeningNet, Florida began
forwarding all N. meningitidis isolates to CDC for antimicrobial
susceptibility testing in late 2008.
§
In 2008, a
total of 4 isolates were tested, all of which were susceptible to
penicillin, ceftriaxone, ciprofloxacin, rifampin, and azithromycin.
§
2009
AMR MeningNet Section (coming soon)
·
Outbreak
Investigations - for summaries of selected investigations of outbreaks
related to healthcare associated infections and/or antimicrobial resistant
organisms conducted by the Florida Department of Health and Florida's County
Health Departments, click
here.
·
The
Antimicrobial Resistance Monitoring (ARM) Program is an ongoing project
designed to document trends in antimicrobial susceptibility patterns and
identify relationships between antibiotic use and resistance rates.
·
CDC has more
extensive surveillance systems in place in different parts of the U.S. Read
more about them
here. |
